327 related articles for article (PubMed ID: 34213069)
1. Evolution of systemic treatment for advanced hepatocellular carcinoma.
Wu TC; Shen YC; Cheng AL
Kaohsiung J Med Sci; 2021 Aug; 37(8):643-653. PubMed ID: 34213069
[TBL] [Abstract][Full Text] [Related]
2. Immunomodulatory Effects of Current Targeted Therapies on Hepatocellular Carcinoma: Implication for the Future of Immunotherapy.
Lin YY; Tan CT; Chen CW; Ou DL; Cheng AL; Hsu C
Semin Liver Dis; 2018 Nov; 38(4):379-388. PubMed ID: 30357775
[TBL] [Abstract][Full Text] [Related]
3. Current status of molecularly targeted therapy for hepatocellular carcinoma: basic science.
Tanaka S; Arii S
Int J Clin Oncol; 2010 Jun; 15(3):235-41. PubMed ID: 20505971
[TBL] [Abstract][Full Text] [Related]
4. Potentiality of immunotherapy against hepatocellular carcinoma.
Tsuchiya N; Sawada Y; Endo I; Uemura Y; Nakatsura T
World J Gastroenterol; 2015 Sep; 21(36):10314-26. PubMed ID: 26420958
[TBL] [Abstract][Full Text] [Related]
5. Challenges of combination therapy with immune checkpoint inhibitors for hepatocellular carcinoma.
Cheng AL; Hsu C; Chan SL; Choo SP; Kudo M
J Hepatol; 2020 Feb; 72(2):307-319. PubMed ID: 31954494
[TBL] [Abstract][Full Text] [Related]
6. Combination treatment including targeted therapy for advanced hepatocellular carcinoma.
Lin J; Wu L; Bai X; Xie Y; Wang A; Zhang H; Yang X; Wan X; Lu X; Sang X; Zhao H
Oncotarget; 2016 Oct; 7(43):71036-71051. PubMed ID: 27626176
[TBL] [Abstract][Full Text] [Related]
7. Therapeutics for advanced hepatocellular carcinoma: Recent advances, current dilemma, and future directions.
Zhu J; Yin T; Xu Y; Lu XJ
J Cell Physiol; 2019 Aug; 234(8):12122-12132. PubMed ID: 30644100
[TBL] [Abstract][Full Text] [Related]
8. Evolution of systemic therapy of advanced hepatocellular carcinoma.
Yau T; Chan P; Epstein R; Poon RT
World J Gastroenterol; 2008 Nov; 14(42):6437-41. PubMed ID: 19030192
[TBL] [Abstract][Full Text] [Related]
9. [Hepatocellular carcinoma: novel therapeutic approaches].
Mohr L
Praxis (Bern 1994); 2007 Apr; 96(14):553-62. PubMed ID: 17455567
[TBL] [Abstract][Full Text] [Related]
10. Emerging drugs for the treatment of hepatocellular carcinoma.
Ayoub WS; Jones PD; Yang JD; Martin P
Expert Opin Emerg Drugs; 2022 Jun; 27(2):141-149. PubMed ID: 35642526
[TBL] [Abstract][Full Text] [Related]
11. Immune checkpoint blockade in advanced hepatocellular carcinoma: an update and critical review of ongoing clinical trials.
Harding JJ
Future Oncol; 2018 Sep; 14(22):2293-2302. PubMed ID: 29663837
[TBL] [Abstract][Full Text] [Related]
12. [Drug research and development and unmet needs for advanced-stage hepatocellular carcinoma].
Zhou HB; Hu HP
Zhonghua Gan Zang Bing Za Zhi; 2024 Apr; 32(4):306-311. PubMed ID: 38733184
[TBL] [Abstract][Full Text] [Related]
13. Molecularly targeted therapy for advanced hepatocellular carcinoma in 2012: current status and future perspectives.
Zhu AX
Semin Oncol; 2012 Aug; 39(4):493-502. PubMed ID: 22846866
[TBL] [Abstract][Full Text] [Related]
14. New Frontiers in the Medical Therapy of Hepatocellular Carcinoma.
Fulgenzi CAM; D'Alessio A; Talbot T; Gennari A; Openshaw MR; Demirtas CO; Cortellini A; Pinato DJ
Chemotherapy; 2022; 67(3):164-172. PubMed ID: 34999584
[TBL] [Abstract][Full Text] [Related]
15. Innovative molecular targeted agents in hepatocellular carcinoma: new gladiators on the arena.
Ferri J; Dockx Y; Vonghia L; Papadimitriou K; Rasschaert M; Francque S; Peeters M; Rolfo C
Minerva Chir; 2017 Jun; 72(3):206-218. PubMed ID: 28198177
[TBL] [Abstract][Full Text] [Related]
16. Development of systemic therapy for hepatocellular carcinoma at 2013: updates and insights.
Chan SL; Yeo W
World J Gastroenterol; 2014 Mar; 20(12):3135-45. PubMed ID: 24696599
[TBL] [Abstract][Full Text] [Related]
17. Systemic therapy for advanced hepatocellular carcinoma: past, present, and future.
Giglia JL; Antonia SJ; Berk LB; Bruno S; Dessureault S; Finkelstein SE
Cancer Control; 2010 Apr; 17(2):120-9. PubMed ID: 20404795
[TBL] [Abstract][Full Text] [Related]
18. Molecular targeted therapy of advanced hepatocellular carcinoma beyond sorafenib.
Yau T; Pang R; Chan P; Poon RT
Expert Opin Pharmacother; 2010 Sep; 11(13):2187-98. PubMed ID: 20707757
[TBL] [Abstract][Full Text] [Related]
19. Angiogenesis in hepatocellular carcinoma: the retrospectives and perspectives.
Sun HC; Tang ZY
J Cancer Res Clin Oncol; 2004 Jun; 130(6):307-19. PubMed ID: 15034787
[TBL] [Abstract][Full Text] [Related]
20. [Status Quo and Development of Immunotherapy for Hepatocellular Carcinoma].
Wang T; Wang WT
Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 May; 54(3):692-698. PubMed ID: 37248607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]